ClinicalTrials.govpublic full text
Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic Melanoma
melanoma (skin)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 398197
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.